Home › Funds › FCPM III SERVICES B.V. › NAMS

FCPM III SERVICES B.V. position in NAMS

NEWAMSTERDAM PHARMA COMPANY · Health Care

FCPM III SERVICES B.V. reported holding 8,490,353 shares of NAMS (NEWAMSTERDAM PHARMA COMPANY) in its Q2 2026 13F filing — a position valued at US$287.7M, representing 38.34% of its reported portfolio and ranking #1 among its reported holdings. FCPM III SERVICES B.V. has disclosed NAMS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)8.49M sh
Reported value held$287.74M
Portfolio Weight38.34%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FCPM III SERVICES B.V.'s NAMS position evolved

FCPM III SERVICES B.V. first disclosed a stake in NAMS in Q4 2023 at 11,831,461 shares (US$132.2M). The position peaked in Q4 2025 at 9,198,900 shares, worth US$322.7M. Across 11 filings, FCPM III SERVICES B.V. increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 8,490,353 shares valued at US$287.7M — a reduction of -708,547 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 11.83M $132.16M New
Q1 2024 11.83M $279.81M Hold
Q2 2024 11.83M $227.28M Hold
Q3 2024 11.83M $196.40M Hold
Q4 2024 10.60M $272.35M Reduce
Q1 2025 10.94M $223.85M Add
Q2 2025 10.63M $192.55M Reduce
Q3 2025 9.21M $262.00M Reduce
Q4 2025 9.20M $322.70M Hold
Q1 2026 9.20M $294.46M Hold
Q2 2026 8.49M $287.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAMS and 13F data

NAMS (NEWAMSTERDAM PHARMA COMPANY) is a Health Care company. 43 other funds we track also report a position in NAMS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$613.0M), RA CAPITAL MANAGEMENT, L.P. (US$323.7M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAMS

All NAMS fund holders →

FAQ

How long has FCPM III SERVICES B.V. held NAMS?

FCPM III SERVICES B.V. has disclosed NAMS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is FCPM III SERVICES B.V.'s current position in NAMS?

As of Q2 2026, FCPM III SERVICES B.V. holds 8.49M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), valued at $287.74M, representing 38.34% of its reported portfolio and ranking #1.

Has FCPM III SERVICES B.V. been buying or selling NAMS?

In the latest 13F filing (Q2 2026), FCPM III SERVICES B.V. reduced its position in NAMS. The position peaked in Q4 2025 at 9.20M shares.

Which other funds hold NAMS?

Other major institutional holders of NAMS include Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., DEERFIELD MANAGEMENT COMPANY, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.